About us
We are passionate about the use of science and computational intelligence to push the boundaries of medical understanding and diagnostics. We aim to become a trusted provider of responsible and clinically validated tools to improve healthcare worldwide for early diagnosis, better disease treatment, and equal access to the best medical advice.
Research
The team exploits its research experience carried out at top-ranked institutions at the forefront of AI and medicine, including Oxford, Cambridge, and Karolinska. OIA’s founders have published more than 200 papers in all the top-ranked journals in the areas of Artificial Intelligence, computational medicine, and systems immunology.
Integrative Teams
Our cross-disciplinary team consists of AI experts, medical leaders, and pioneers in IoT and optical engineering working at the forefront of science and technology. With our multidisciplinary approach, we are able to tackle some of the most pressing human health challenges, such as infection, cancer, antibiotic resistance, and tropical diseases from a technological and commercial-viability point of view.
Our Team
Dr. Hector Zenil
Founder & Owner
Ph.D. in Computer Science (Lille) & Ph.D. in Logic (Paris Sorbonne). Associate Professor in Bio and Healthcare Engineering at King’s College London. Former lab leader & senior researcher affiliated with five of the world’s top universities in AI (Cambridge, Oxford, MIT, CMU) & Medicine (Karolinska). He wrote code behind Siri, Alexa, and ChatGPT that deals with factual contextual questions. He was a Payload team member for the NASA Mars Biosatellite project at MIT. He is a board and advisor member of multiple startups around the world.
Pamela Winsor
Chair
eMBA (2000) at St. Mary’s University, Halifax and the ICD.D (2015) with Rotman School of Business, Toronto. 20+ years as a Senior Healthcare Executive, including 14 years at Medtronic as CMO, the world largest medical device manufacturer. Member of the Canadian College of Health Leaders, and a leader visionary in patient-centric healthcare. Rotman, Judy Project Alumni and an executive coach.
Allan Bezanson
Director
Director of several public and private companies. Current CEO of the pioneering AI publicly traded fintech company QuantGate Systems Inc. (OTCQB: QGSI). He has a background in private equity & financial services with a demonstrated history of successfully building businesses as a leader and investor. Notable past successes Nowsco, Altus, Bluewave Energy, FCF Capital, Polaris, and Voxtur.
Abel Archundia
Advisor
Former Head of Digital Transformation and IT for Bayer Pharmaceuticals. He is a member of the group’s Digital Transformation Board as well as a member of the Bayer Group IT board. Former Global Head, Novartis TechOps/QA IT and Sandoz Division IT of Novartis. Former supply chain manager for Dell and as General Manager (US$500M business) on the vendor side. Chief Information Officer with broad experience (geo, functional & business), especially in large-scale transformation efforts (PMIs, IT Transformation, process governance).
Prof. Jesper N. Tegnér
Director
Ph.D. in neurosciences (Karolinska). Professor of Bioscience and Computer Science (KAUST) specialised in AI applied to systems medicine and single-cell genomics. Founder of award-winning startups in Sweden. Chaired full professorship in Computational Biology, the first of its kind in Sweden and Strategic chaired full professor in Computational Medicine, Karolinska Institutet & Division of Clinical Epidemiology, Karolinska Hospital.
Dr. Roger Ferguson, Jr.
Observer
J.D., and a Ph.D. in economics (Harvard). He has a significant stake in OIA as the second-largest individual shareholder after the Founder. Past President and CEO of TIAA, a Fortune 100 financial services organization. Former head of financial services for Swiss Re and Chairman of Swiss Re America Holding Corporation. Former Vice Chairman of the Board of Governors of the U.S. Federal Reserve. He serves on the boards of Alphabet, Inc. and on the boards of the Institute for Advanced Study, and Memorial Sloan Kettering Cancer Center, among others.
Prof. Petter Brodin
Garfield Weston Chair & Professor of Paediatric Immunology (Imperial College) & Professor of Paediatric immunology (Karolinska Institutet). Develops novel methods to describe human immune system variation
Prof. Patrick Tighe
Professor of Molecular Immunology (Nottingham) specialised in molecular cloning, T cell receptor analysis, fluorescent detection technologies & immunoassay tech.
Dr. Amos Burke
Lead oncologist at the Department of Paediatric Haematology, Oncology & Palliative Care, NHS Cambridge University Trust. He is a member of the National Cancer Research Institute.
Dr. Jason Berman
Full Professor of Paediatrics and Cellular & Molecular Medicine at the University of Ottawa. Clinician, researcher and thought leader. Serves as CEO & Scientific Director of the Children’s Hospital of Eastern Ontario (CHEO).
Dr. Corey Cutler
MD, MPH, FRCP(C) is the Medical Director of the Stem Cell Transplantation Program at the Dana-Farber Cancer Institute & an Associate Professor of Medicine at Harvard Medical School. Author of 300+ publications and 40 reviews and book chapters.
Dr. Narsis A. Kiani
Lab leader and senior researcher at the Department of Oncology-Pathology and the Algorithmic Dynamics Lab, Karolinska Institute. BEng in medical engineering and a BSc in pure mathematics, MSc, and PhD in applied mathematics. She was a VINNMER (Vinnova-Marie curie) Fellow.
Tony Cambridge
Tony Cambridge is the Managing Director of Thornhill Healthcare Events & Consultancy, and Lead Biomedical Scientist in the Pathology Management team of a major trauma centre and acute care NHS hospital in England. With over 25 years’ experience in pathology & diagnostics.
Prof. Weizi Li
Associate Professor of Informatics & Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. Principal Investigator of the EPSRC project on the ‘Future blood testing for inclusive monitoring and personalised analytics Network+’.
Martin Korbmacher
Founder and Managing Partner of Event Horizon Capital & Advisory GmbH. Event Horizon is a Corporate Finance Boutique as well as an investment vehicle. He holds the position of Chairman of the supervisory board of the publicly listed flatexDEGIRO AG, and is also Chairman of the supervisory board of the publicly listed SGT Private Equity GmbH & Co. KGaA.
Dr. Miron Derchansky
Former VP of Innovation & New Ventures at LEO Pharma in Israel and Canada. Former VP of Strategy at LexisNexis Canada. Former Senior manager consultant at Monitor Deloitte. PhD in Neuroscience & Physiology from Toronto U. & an MBA from Amherst U.
Dr. Syed Ahsan Raza
Senior Clinical Scientist at the Trauma and Transfusion Medicine Research Center, University of Pittsburgh, with expertise spanning from epidemiology (Ph.D.), to infection disease, big data analytics, clinical adaptive trials, Bayesian analysis, and AI. Former researcher (cancer) at Baylor College of Medicine from where he received his MD followed by postgraduate studies at Harvard. Over 50 peer-reviewed publications.
Dr. Andrew King
Consultant haematologist and clinical lead for haemato-oncology at Cambridge University Hospitals NHS Foundation Trust. Specialised in acute leukaemia, myeloma and bone marrow, transplantation/cellular therapy. Principal or sub-investigator on several late phase clinical trials. DPhil in molecular biology at the Weatherall Institute, University of Oxford. Co-author of Lecture Notes in Haematology.
Dr. Hamid Sadri
Hamid Sadri is the Director of Policy, Health Economics & Outcomes Research at Medtronic ULC. Holds a doctorate in clinical pharmacy and two graduate degrees, in health economics and healthcare management respectively, from the University of Toronto. He is is a registered pharmacist in Ontario and is a member of the
Canadian College of Health Leaders.
Dr. Hector Zenil
Chief Visionary Officer
Ph.D. in Computer Science (Lille) & Ph.D. in Logic (Paris Sorbonne). Associate Professor in Bio & Healthcare Engineering at King’s College London. Former lab leader & senior researcher affiliated with four of the world’s top 5 universities in AI (Oxford, Cambridge, MIT, CMU). Wrote code used by and behind Siri, Alexa, and ChatGPT that deals with factual questions. Board trustee at the British Society of Ageing Research.
Michelle Lea
Chief Executive Officer
Lifelong career in medical devices, healthcare & startup ventures (with successful exits and deals worth $300 million) in CEO, COO, & CCO positions. She has held various roles in the NHS, including Head of Surgery & Turnaround at Ipswich Hospital, Director of Surgery at Milton Keynes, & Turnaround Director at Kettering NHS. Recipient of the 2018 Leadership Fellow of Windsor Castle, 2019 IFAFH Top 100 Healthcare Leaders, & HSJ Patient Safety Award.
Prof. Kourosh Saeb-Parsy
Chief Medical Officer
MD & PhD in (neurosciences). Professor in Transplantation, group leader, Department of Surgery, Cambridge University. NHS Consultant Transplant Surgeon. Specialises in immunogenicity of cancer and regenerative cellular therapies. Multiple experience leading start-ups to success.
Hugo Phillips
Director of Product Delivery and Facilities
Senior executive with a proven track record of achieving strategic and operational objectives as COO across a number of industry sectors including health technology, digital technology, marketing technology, financial services and engineering.
Steven Timcke
Chief Financial Officer
25+ years’ experience building long lasting and trusting relationships with owners and stakeholders as FD and CFO. Extensive experience in manufacturing/ engineering. Portfolio Finance Director and CFO on behalf of The FD & CFO Centre, Oxford, UK.
Dr. Alfonso Ferrandez
Chief Technology & Product Officer
PhD in Computational BioFluid Dynamics (Leeds) applied to blood vessels leading to an algorithm currently in use by NASA to vet astronauts’ health. Expert in computer vision. Designed & built one of the largest IoT networks in the UK. Former CTO of DoctorLink building the entire remote-care platform (MD Class IIa/IIb).
Maddie Rippon
General Counsel
20+ years experience working in tech. GC at Wayra, Telefonica's open innovation hub, and at Coatsink, part of the Thunderful Games AB group. She is co-founder of Particular Legal, acquired in 2018 by Mincoffs. Expert in dispute resolution and contracts.
Imad Alabed
Product Manager
B.Eng in Electrical Engineering (Boston) in semiconductors, communications and computer systems. Former Senior Director for Product Management, responsible for developing cloud transformation strategies and reporting directly to Avolin’s CEO. CRM and KM Guru, SaaS strategist with 20+ years of experience.
Mariana G. Castellón
Procurement Manager
Masters in Translation and Interpretation specialising in legal & medical. She has experience in corporate communication at multinational electronics & manufacturing co’s (Research in Motion, Cisco), compliance & ISO standards auditing.
Daniel Mannion
Head of Global Compliance
Masters in Molecular and Cellular Biochemistry (Oxford). Medical Device Compliance Quality Assurance Specialist (CE Marking, FDA (510(k)), ISO 13485 Lead Auditor, 6 Sigma Green Belt, Dipl. Leadership and Management.
OIA Centres
Headquartered outside London in the UK & operating in several countries.
Head Office
Oxford Immune Algorithmics Ltd
Davidson House, Forbury Square, RG1, 3EU, Reading UK
Algocyte Canada
130 Adelaide Street West, Suite 3002 Toronto, ON
Canada M5H 3P5
AI Research Center
Immune Algorithmics Middle
East. PO Box: 46617, 15th Floor, WeWork Hub71
Abu Dhabi, UAE
AI Research and
Software Development
Oxford Immune Algorithmics Ltd
6 Richfield Place, 12 Richfield Avenue
RG1 8EQ, Reading
UK
Global HQs & Biolab
OIA France
8 Avenue des Champs-Élysées
75008 Paris
France
Commercial